BSX · Boston Scientific Corp

$51.83 +0.14 (+0.27%) At close · Aug 14

Market Cap

$75.11B

1.45B

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,442,603	—	$13,608,056	$3,749,980	$4,002,001	$287,799	$23,532,050
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiovascular	$892,604	—	$4,309,282	$1,187,463	$1,458,001	$45,657	$8,042,997
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$744,822	—	$3,447,272	$949,962	$1,012,501	$219,667	$6,534,719
Daniel Brennan	Former Executive Vice President and Chief Financial Officer	$660,990	—	$3,447,272	$949,962	$1,098,004	$36,738	$6,282,896
Jonathan Monson	Executive Vice President and Chief Financial Officer	$591,848	—	$1,624,898	$1,170,504	$840,000	$38,453	$6,083,679
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$702,042	—	$1,995,566	$549,989	$793,126	$59,238	$4,159,959
Vance R. Brown	Senior Vice President, General Counsel and Corporate Secretary	$659,086	—	$1,723,636	$474,960	$897,751	$45,286	$3,920,644

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,400,000	—	$12,229,998	$3,562,493	$3,743,250	$193,394	$21,420,801
Daniel Brennan	Executive Vice President and Chief Financial Officer	$843,146	—	$3,261,199	$949,983	$1,472,667	$25,148	$6,687,005
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$842,360	—	$3,089,627	$899,991	$1,319,632	$34,317	$6,335,804
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$708,884	—	$2,402,895	$699,995	$957,206	$39,036	$5,013,447
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$680,411	—	$1,887,957	$549,993	$770,627	$48,092	$4,027,076

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,400,000	—	$10,472,753	$3,124,984	$3,244,150	$190,181	$18,723,735
Daniel Brennan	Executive Vice President and Chief Financial Officer	$801,528	—	$2,764,794	$825,000	$1,323,938	$23,677	$5,829,147
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$793,560	—	$2,764,794	$825,000	$1,016,657	$27,372	$5,592,519
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$672,077	—	$2,010,731	$599,998	$756,872	$62,299	$4,273,657
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$652,646	—	$1,759,429	$524,992	$734,422	$51,498	$3,782,995

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,395,178	—	$9,924,100	$2,874,985	$2,278,500	$92,530	$16,941,961
Daniel Brennan	Executive Vice President and Chief Financial Officer	$765,959	—	$2,588,909	$749,991	$900,240	$22,106	$5,252,206
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$740,178	—	$2,416,234	$699,996	$764,649	$23,529	$4,764,586
Arthur C. Butcher	Executive Vice President and Group President, MedSurg and Asia Pacific	$634,329	—	$1,903,298	$799,984	$471,120	$295,401	$4,173,434
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$631,986	—	$1,812,175	$524,989	$482,251	$35,843	$3,562,244

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,344,329	—	$9,126,292	$2,749,999	$2,346,000	$137,419	$16,064,039
Daniel Brennan	Executive Vice President and Chief Financial Officer	$692,183	—	$2,281,542	$687,497	$684,250	$24,496	$4,429,827
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$699,130	—	$2,074,084	$624,999	$843,180	$23,191	$4,309,535
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$598,249	—	$1,659,292	$499,992	$573,546	$35,085	$3,456,145

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$666,878	—	$8,395,367	$2,749,991	$1,485,000	$76,873	$13,773,795
Joseph M. Fitzgerald	Executive Vice President and Group President, Cardiology	$568,679	—	$1,907,997	$1,624,991	$414,010	$22,754	$4,598,333
Daniel Brennan	Executive Vice President and Chief Financial Officer	$560,422	—	$1,907,997	$624,992	$455,206	$21,204	$3,668,993
Edward F. Mackey	Executive Vice President, Operations	$497,670	—	$2,144,740	$374,991	$391,374	$20,692	$3,599,526
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	$495,001	—	$1,450,047	$474,996	$350,179	$30,563	$2,956,196

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,274,740	—	$9,087,249	$2,699,992	$1,996,800	$296,069	$15,764,140
Daniel Brennan	Executive Vice President and Chief Financial Officer	$655,437	—	$1,977,244	$587,497	$583,482	$37,241	$4,031,286
Joseph M. Fitzgerald	Executive Vice President and President, Interventional Cardiology	$667,416	—	$2,103,497	$624,989	$546,760	$22,732	$4,025,457
Kevin J. Ballinger	Executive Vice President and President, Interventional Cardiology	$587,382	—	$1,598,620	$474,995	$460,205	$20,013	$3,368,572
Edward F. Mackey	Executive Vice President, Operations	$577,398	—	$1,472,367	$437,491	$520,282	$34,851	$3,198,962

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,234,630	—	$7,643,884	$2,499,993	$2,128,770	$151,692	$13,970,901
Joseph M. Fitzgerald	Executive Vice President and President, Interventional Cardiology	$639,958	—	$1,910,971	$624,994	$582,425	$32,636	$4,036,318
Daniel Brennan	Executive Vice President and Chief Financial Officer	$621,637	—	$1,719,882	$562,495	$626,736	$33,058	$3,665,825
Kevin J. Ballinger	Executive Vice President and President, Interventional Cardiology	$567,362	—	$1,337,622	$437,498	$448,918	$45,571	$2,841,486

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Mahoney	Chairman of the Board, President and Chief Executive Officer	$1,179,452	—	$7,225,607	$2,249,995	$1,890,000	$122,254	$13,084,452
Joseph M. Fitzgerald	Executive Vice President and President, Rhythm Management	$564,740	—	$1,435,716	$2,949,992	$595,139	$19,641	$5,838,997
Daniel Brennan	Executive Vice President and Chief Financial Officer	$593,194	—	$1,766,253	$549,994	$504,037	$21,141	$3,632,769
Kevin J. Ballinger	Executive Vice President and President, Interventional Cardiology	$543,151	—	$1,316,086	$412,493	$346,500	$18,963	$2,808,571

Executive changes

Person	Role	Change	Effective	Filed
Christophe P. Weber	director	Appointed	2026-02-18	2026-02-23
Catherine R. Smith	director	Appointed	2026-02-18	2026-02-23
Jeffrey B. Mirviss	Executive Vice President and President, Peripheral Interventions	Retired	2025-12-01	2025-09-04
Jonathan Monson	Executive Vice President and Chief Financial Officer	Appointed	2025-06-30	2025-04-23
Daniel J. Brennan	Executive Vice President and Chief Financial Officer	Retired	2025-06-29	2025-04-23
David C. Habiger	director of the Company	Appointed	2024-07-30	2024-07-30
Cheryl Pegus, MD, MPH	director	Appointed	2024-05-08	2024-05-10
Emily Woodworth (Collins)	Senior Vice President, Global Controller and Chief Accounting Officer	Appointed	2024-03-01	2024-01-31
Jonathan Monson	Senior Vice President, Investor Relations	Appointed	2024-03-01	2024-01-31
Susan E. Morano	director	Appointed	2023-06-27	2023-06-27
Jessica L. Mega	director	Appointed	2023-06-27	2023-06-27

Key facts CIK 885725 CUSIP 101137107 13F (30d) 1360 filings 1300 filers Visit website Investor relations